Edwards Lifesciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. 

CEO
Bernard J. Zovighian
CEOBernard J. Zovighian
Employees
15,800
Employees15,800
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1958
Founded1958
Employees
15,800
Employees15,800

EW Key Statistics

Market cap
48.26B
Market cap48.26B
Price-Earnings ratio
55.17
Price-Earnings ratio55.17
Dividend yield
Dividend yield
Average volume
5.51M
Average volume5.51M
High today
$83.25
High today$83.25
Low today
$79.86
Low today$79.86
Open price
$80.22
Open price$80.22
Volume
9.81M
Volume9.81M
52 Week high
$83.25
52 Week high$83.25
52 Week low
$64.89
52 Week low$64.89

EW News

Simply Wall St 9h
Will New Valve Data Help Edwards Lifesciences Solidify Its Competitive Position in Structural Heart?

Edwards Lifesciences recently reported positive clinical data supporting its mitral and tricuspid valve therapies, along with long-term results from the PARTNER...

Will New Valve Data Help Edwards Lifesciences Solidify Its Competitive Position in Structural Heart?
TipRanks 14h
Edwards Lifesciences price target raised to $87 from $82 at Truist

Truist raised the firm’s price target on Edwards Lifesciences (EW) to $87 from $82 and keeps a Hold rating on the shares. The company had a positive day at TCT2...

TipRanks 17h
Positive Outlook on Edwards Lifesciences Reinforced by PARTNER 3 Study Results

Edwards Lifesciences, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Marie Thibault from BTIG maintained a Buy rating...

Analyst ratings

56%

of 36 ratings
Buy
55.6%
Hold
41.7%
Sell
2.8%

More EW News

TipRanks 17h
Positive Long-Term Outlook for Edwards Lifesciences’ TAVR Procedures Reinforces Buy Rating

Edwards Lifesciences, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Travis Steed from Bank of America Securities main...

TipRanks 1d
Edwards Lifesciences’ INNOVALVE System: A Promising Step in Mitral Valve Treatment

Edwards Lifesciences Corp. ((EW)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at...

TipRanks 1d
Edwards Lifesciences’ PROGRESS Trial: A Game-Changer in Aortic Stenosis Treatment?

Edwards Lifesciences Corp. ((EW)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at...

TipRanks 1d
Edwards Lifesciences’ New Study on Continuous Blood Pressure Monitoring: What Investors Should Know

Edwards Lifesciences Corp. ((EW)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at...

TipRanks 1d
Edwards Lifesciences’ PASCAL System: A Pivotal Study Update

Edwards Lifesciences Corp. ((EW)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at...

TipRanks 1d
Edwards Lifesciences’ ENCIRCLE Trial: A New Hope for Mitral Regurgitation Patients

Edwards Lifesciences Corp. ((EW)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50...

TipRanks 1d
Edwards Lifesciences Advances Monitoring Tech with New Study

Edwards Lifesciences Corp. ((EW)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at...

People also own

Based on the portfolios of people who own EW. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.